Neuroprotection by selective nitric oxide synthase inhibition at 24 hours after perinatal hypoxia-ischemia

Stroke. 2002 Sep;33(9):2304-10. doi: 10.1161/01.str.0000028343.25901.09.

Abstract

Background and purpose: Perinatal hypoxia-ischemia is a major cause of neonatal morbidity and mortality. Until now no established neuroprotective intervention after perinatal hypoxia-ischemia has been available. The delay in cell death after perinatal hypoxia-ischemia creates possibilities for therapeutic intervention after the initial insult. Excessive nitric oxide and reactive oxygen species generated on hypoxia-ischemia and reperfusion play a key role in the neurotoxic cascade. The present study examines the neuroprotective properties of neuronal and inducible but not endothelial nitric oxide synthase inhibition by 2-iminobiotin in a piglet model of perinatal hypoxia-ischemia.

Methods: Twenty-three newborn piglets were subjected to 60 minutes of hypoxia-ischemia, followed by 24 hours of reperfusion and reoxygenation. Five additional piglets served as sham-operated controls. On reperfusion, piglets were randomly treated with either vehicle (n=12) or 2-iminobiotin (n=11). At 24 hours after hypoxia-ischemia, the cerebral energy state, presence of vasogenic edema, amount of apparently normal neuronal cells, caspase-3 activity, amount of terminal deoxynucleotidyl transferase-mediated dUTP-biotin in situ nick end labeling (TUNEL)-positive cells, and degree of tyrosine nitration were assessed.

Results: A 90% improvement in cerebral energy state, 90% reduction in vasogenic edema, and 60% to 80% reduction in apoptosis-related neuronal cell death were demonstrated in 2-iminobiotin-treated piglets at 24 hours after hypoxia- ischemia. A significant reduction in tyrosine nitration in the cerebral cortex was observed in 2-iminobiotin-treated piglets, indicating decreased formation of reactive nitrogen species.

Conclusions: Simultaneous and selective inhibition of neuronal and inducible nitric oxide synthase by 2-iminobiotin is a promising strategy for neuroprotection after perinatal hypoxia-ischemia.

MeSH terms

  • Animals
  • Animals, Newborn
  • Apoptosis / drug effects
  • Biotin / analogs & derivatives*
  • Biotin / pharmacology*
  • Brain / blood supply
  • Brain / drug effects
  • Brain / pathology
  • Brain / physiopathology
  • Brain Edema / etiology
  • Brain Edema / pathology
  • Brain Edema / prevention & control
  • Caspase 3
  • Caspases / metabolism
  • Disease Models, Animal
  • Energy Metabolism / drug effects
  • Enzyme Inhibitors / pharmacology
  • Hypoxia-Ischemia, Brain / complications
  • Hypoxia-Ischemia, Brain / drug therapy*
  • Hypoxia-Ischemia, Brain / physiopathology
  • Immunohistochemistry
  • In Situ Nick-End Labeling
  • Magnetic Resonance Spectroscopy
  • Neuroprotective Agents / pharmacology*
  • Nitric Oxide Synthase / antagonists & inhibitors*
  • Reperfusion Injury / etiology
  • Reperfusion Injury / pathology
  • Reperfusion Injury / prevention & control*
  • Survival Rate
  • Swine
  • Treatment Outcome
  • Tyrosine / metabolism

Substances

  • Enzyme Inhibitors
  • Neuroprotective Agents
  • Tyrosine
  • Biotin
  • Nitric Oxide Synthase
  • Caspase 3
  • Caspases
  • 2-iminobiotin